0000899243-21-002025.txt : 20210114
0000899243-21-002025.hdr.sgml : 20210114
20210114160508
ACCESSION NUMBER: 0000899243-21-002025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210112
FILED AS OF DATE: 20210114
DATE AS OF CHANGE: 20210114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelly Timothy P
CENTRAL INDEX KEY: 0001754067
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38433
FILM NUMBER: 21528777
MAIL ADDRESS:
STREET 1: C/O HOMOLOGY MEDICINES, INC.
STREET 2: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Homology Medicines, Inc.
CENTRAL INDEX KEY: 0001661998
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473468154
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 781-301-7277
MAIL ADDRESS:
STREET 1: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-12
0
0001661998
Homology Medicines, Inc.
FIXX
0001754067
Kelly Timothy P
C/O HOMOLOGY MEDICINES, INC.
ONE PATRIOTS PARK
BEDFORD
MA
01730
0
1
0
0
See Remarks
Common Stock
2021-01-12
4
M
0
500
6.6314
A
500
D
Common Stock
2021-01-12
4
S
0
500
13.00
D
0
D
Employee Stock Options
6.6314
2021-01-12
4
M
0
500
0.00
D
2027-12-06
Common Stock
500
45000
D
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020.
The option vests and becomes exercisable upon the Reporting Person's completion of each full month of service after January 1, 2018, so that such option will become fully vested on January 1, 2022.
Chief Technical Operations Officer
/s/ Bradford Smith, Attorney-in-Fact for Timothy P. Kelly
2021-01-14